NSEAnalysts/Institutional Investor Meet/Con. Call Updates5 Aug 2026 · 5 Aug 2026, 09:43 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Cohance Lifesciences Limited · COHANCE

✦ AI SummaryResults

Cohance Lifesciences Limited has uploaded the audio recording of its conference call for the quarter ended 30 June 2026 on its website.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cohance Lifesciences Limited has informed the Exchange about Link of Recording

Attachments (1)

📄

SUVENPHARMROHIT_05082026214319_Cohance_concall_audiolink05082026.pdf

pdf

Download →
View document text
5 August 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Audio recording of the conference call for the quarter ended 30 June 2026 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our results conference call intimation dated 23 July 2026, that audio recording of the conference call for the quarter ended 30 June 2026 held on Wednesday, 5 August 2026, has been uploaded on the Company's website and available at the link: https://www.cohance.com/wp-content/uploads/2026/08/Audio-5Aug26.mp3 This is for your information and record. Thanking you. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir k Mishra Company Secretary & Compliance Officer